Latest Kaiser Health News Stories
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.
From A to zinc and all the dietary supplements in between, KHN senior correspondent Liz Szabo gives you the dope on whether popping vitamins does you any good.
Nicotine-loaded e-cig juices that spoof popular treats — marketed to help adults kick the smoking habit— instead may be luring youths into addiction. California Healthline’s Facebook Live peeled back the curtains on this wolf in sheep’s clothing.
About 2,000 Californians died of opioid overdoses in 2016, but access to medications that treat addiction is limited in some parts of the state.
Listen and learn from this Kaiser Health News’ Facebook Live event. “Navigating Aging” columnist Judith Graham led a discussion about dementia, one of the most challenging chronic conditions for individuals and their families — which affects millions of American families.
In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.
In this chat, KHN’s Julie Appleby offers a progress report on the 2018 sign up season.
In this Facebook Live chat, KHN’s Julie Appleby answers questions about what’s changed for 2018 open enrollment.
In this Facebook Live chat, KHN’s Jay Hancock answers questions about President Donald Trump’s announcement that he will end federal payments for the Affordable Care Act’s cost-sharing reductions.
In this Facebook Live, KHN’s Julie Appleby answers questions about President Donald Trump’s executive order regarding insurance.
In this Facebook Live, KHN’s Julie Rovner talks to Bruce Lesley, president of First Focus, about the current state of play on CHIP reauthorization.
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.